- Home
- TLS vs NBTX Comparison
TLS vs NBTX Comparison
Compare TLS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLS
- NBTX
- Stock Information
- Founded
- TLS 1969
- NBTX 2003
- Country
- TLS United States
- NBTX France
- Employees
- TLS N/A
- NBTX N/A
- Industry
- TLS EDP Services
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- TLS Technology
- NBTX Health Care
- Exchange
- TLS Nasdaq
- NBTX Nasdaq
- Market Cap
- TLS 209.4M
- NBTX 211.9M
- IPO Year
- TLS 2020
- NBTX 2020
- Fundamental
- Price
- TLS $2.53
- NBTX $6.54
- Analyst Decision
- TLS Buy
- NBTX Strong Buy
- Analyst Count
- TLS 6
- NBTX 1
- Target Price
- TLS $3.94
- NBTX $8.00
- AVG Volume (30 Days)
- TLS 643.6K
- NBTX 7.5K
- Earning Date
- TLS 08-11-2025
- NBTX 09-17-2025
- Dividend Yield
- TLS N/A
- NBTX N/A
- EPS Growth
- TLS N/A
- NBTX N/A
- EPS
- TLS N/A
- NBTX N/A
- Revenue
- TLS $109,269,000.00
- NBTX N/A
- Revenue This Year
- TLS $35.76
- NBTX N/A
- Revenue Next Year
- TLS $26.83
- NBTX $74.67
- P/E Ratio
- TLS N/A
- NBTX N/A
- Revenue Growth
- TLS N/A
- NBTX N/A
- 52 Week Low
- TLS $1.83
- NBTX $2.76
- 52 Week High
- TLS $4.82
- NBTX $7.29
- Technical
- Relative Strength Index (RSI)
- TLS 36.23
- NBTX 66.43
- Support Level
- TLS $2.40
- NBTX $6.49
- Resistance Level
- TLS $2.93
- NBTX $7.15
- Average True Range (ATR)
- TLS 0.12
- NBTX 0.36
- MACD
- TLS -0.05
- NBTX 0.11
- Stochastic Oscillator
- TLS 17.27
- NBTX 73.88
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.